No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage*
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
B-Lymphocytes / drug effects
-
B-Lymphocytes / metabolism
-
Humans
-
Immunologic Factors / administration & dosage
-
Immunologic Factors / therapeutic use
-
Maximum Tolerated Dose
-
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
-
Rituximab
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Immunologic Factors
-
Rituximab